Diagnosing peri-implant disease using the tongue as a 24/7 detector

J. Ritzer, T. Lühmann, C. Rode, M. Pein-Hackelbusch, I. Immohr, U. Schedler, T. Thiele, S. Stübinger, B. v. Rechenberg, J. Waser-Althaus, F. Schlottig, M. Merli, H. Dawe, M. Karpíšek, R. Wyrwa, M. Schnabelrauch and L. Meinel ()
Additional contact information
J. Ritzer: Universität Würzburg, Am Hubland
T. Lühmann: Universität Würzburg, Am Hubland
C. Rode: Biomaterials Department, Innovent e.V.
M. Pein-Hackelbusch: Universität Düsseldorf
I. Immohr: Universität Düsseldorf
U. Schedler: PolyAn GmbH
T. Thiele: PolyAn GmbH
S. Stübinger: Universität Zürich
B. v. Rechenberg: Universität Zürich
J. Waser-Althaus: Thommen Medical AG
F. Schlottig: Thommen Medical AG
M. Merli: Indent—International Dental Research and Education srl
H. Dawe: Indent—International Dental Research and Education srl
M. Karpíšek: University of Veterinary and Pharmaceutical Sciences
R. Wyrwa: Biomaterials Department, Innovent e.V.
M. Schnabelrauch: Biomaterials Department, Innovent e.V.
L. Meinel: Universität Würzburg, Am Hubland

Nature Communications, 2017, vol. 8, issue 1, 1-8

Abstract: Abstract Our ability of screening broad communities for clinically asymptomatic diseases critically drives population health. Sensory chewing gums are presented targeting the tongue as 24/7 detector allowing diagnosis by “anyone, anywhere, anytime”. The chewing gum contains peptide sensors consisting of a protease cleavable linker in between a bitter substance and a microparticle. Matrix metalloproteinases in the oral cavity, as upregulated in peri-implant disease, specifically target the protease cleavable linker while chewing the gum, thereby generating bitterness for detection by the tongue. The peptide sensors prove significant success in discriminating saliva collected from patients with peri-implant disease versus clinically asymptomatic volunteers. Superior outcome is demonstrated over commercially available protease-based tests in saliva. “Anyone, anywhere, anytime” diagnostics are within reach for oral inflammation. Expanding this platform technology to other diseases in the future features this diagnostic as a massive screening tool potentially maximizing impact on population health.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-017-00340-x Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00340-x

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-017-00340-x

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().